SJS Investment Consulting’s Fennec Pharmaceuticals FENC Stock Holding History

SJS Investment Consulting’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140	Buy	+13	New	+$106	﹤0.01%	2542

Other funds holding FENC

Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return

Eleva Capital Paris, France $343M AUM

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SJS Investment Consulting's FENC Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 13 shares worth $140. The stake represents ﹤0.01% of the portfolio and ranks #2542 among its holdings.

18 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

SJS Investment Consulting held 13 shares of Fennec Pharmaceuticals worth $140 as of Q2 2026.
Fennec Pharmaceuticals was a new SJS Investment Consulting position in Q2 2026.
Fennec Pharmaceuticals made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2542 holding.
18 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.